Qingshuang Wang – Diagnosis of Infectious Diseases – Best Researcher Award

Qingshuang Wang - Diagnosis of Infectious Diseases - Best Researcher Award

Changchun University of Science and Technology - China

AUTHOR PROFILE 

SCOPUS

ROOTS AND ACADEMIC FOUNDATION 🌱

Wang Qingshuang hails from Shuangyashan City in Heilongjiang Province. His academic journey began at Harbin Normal University, where he graduated from the Department of Biology in 2002. Driven by a deep curiosity in scientific advancement, he pursued a Ph.D. in Optics from the Changchun University of Science and Technology, completing it in 2015. His educational path blends biological sciences and optical research—an intersection that would later define his unique research pursuits. In 2005, he broadened his academic experience at Peking University School of Medicine, further shaping his research trajectory. Later, as a visiting scholar at the University of British Columbia in 2017, he gained international exposure, which enriched his scientific outlook. These early academic experiences cultivated a strong foundation for his multidisciplinary research career, particularly in molecular biology, nanotechnology, and biomedical optics.

SCIENTIFIC CAREER AND LEADERSHIP 🧪

Currently, Professor Wang Qingshuang serves as Vice Dean, Professor, and Doctoral Supervisor at the School of Life Sciences and Technology, Changchun University of Science and Technology. His academic roles are bolstered by his active participation in national scientific committees and provincial technology initiatives. As a dissertation and project reviewer, he contributes significantly to educational and scientific standards. His leadership extends into professional organizations such as the Jilin Society of Biochemistry and Molecular Biology and the Innovation and Translational Medicine Professional Committee. Professor Wang not only teaches but also mentors young researchers and supervises Ph.D. students, helping cultivate the next generation of scientific minds. His role as an executive and committee member in several scientific societies underlines his influence in shaping policy and research priorities in biochemistry, molecular diagnostics, and applied biotechnology across Jilin Province and beyond.

INNOVATION IN RESEARCH AND BIOMEDICAL TECHNOLOGY 🔬

With over a decade of research in nano-sustained-release and anti-tumor drugs, Professor Wang Qingshuang has made significant strides in biomedical innovation. His work integrates optical science with molecular biology to create effective delivery systems for therapeutic agents. As a principal investigator, he led a basic scientific research project under the State Administration of Science, Technology and Industry for National Defense and contributed to two National Natural Science Foundation projects. His portfolio includes more than ten key R&D projects in Jilin Province, underscoring his leading role in regional biotech innovation. With over 20 SCI-indexed publications and many more in EI and core journals, Professor Wang’s scientific output reflects both depth and practical impact. His unique approach bridges fundamental science with real-world medical applications, exemplifying the translational potential of interdisciplinary research in drug development and diagnostic systems.

COMBATING COVID-19 WITH SCIENCE 🦠

In 2020, amidst the COVID-19 pandemic, Professor Wang Qingshuang emerged as a key scientific contributor in China’s fight against the virus. Leading his team as the technical head, he developed and implemented droplet digital PCR technology for nucleic acid detection of the novel coronavirus. This advanced diagnostic tool significantly improved detection accuracy and efficiency. In a show of solidarity, Professor Wang's team donated these kits to frontline institutions such as West China Hospital of Sichuan University and People's Hospital of Wuhan University. His leadership and quick response not only aided immediate clinical efforts but also reinforced the value of rapid scientific mobilization during global health crises. For these efforts, his research group—the “Jilin Province Cross-Regional Gene Diagnosis Frontier Technology Science and Technology Innovation and Entrepreneurship Team”—received national recognition from the Ministry of Science and Technology for outstanding contributions in epidemic response.

HONORS AND SCHOLARLY RECOGNITION 🏅

Professor Wang Qingshuang’s research excellence has been celebrated with numerous accolades. He is a two-time recipient of the Jilin Province Science and Technology Award, a prestigious honor recognizing innovation and impact in scientific research. His mentorship in undergraduate innovation has also earned him several first and second prizes in the National Undergraduate Life Science Innovation and Entrepreneurship Competition, highlighting his dedication to education and student development. These awards not only affirm his scientific achievements but also showcase his commitment to fostering young talent in the life sciences. Moreover, his esteemed roles as a reviewer for national academic dissertations and technological projects reflect the scholarly community’s trust in his expertise. These cumulative recognitions illustrate a career defined by both intellectual rigor and influential guidance across the fields of life sciences, diagnostics, and medical biotechnology.

SCIENTIFIC IMPACT AND PUBLIC SERVICE 🌍

Beyond academic circles, Professor Wang Qingshuang’s work has had a measurable impact on public health and scientific policy. His COVID-19 diagnostic innovations directly contributed to safer and more accurate detection methods during a time of urgent global need. As a public contributor, he aligns scientific advancement with societal benefit, often integrating his research with regional health initiatives and policy-making through his role in the Jilin Health Management Society. His position at the interface of research, clinical application, and public welfare allows him to influence how science serves humanity. His vision combines high-level scientific rigor with real-world applications, improving not only patient outcomes but also strengthening regional research infrastructure. Through these actions, Professor Wang embodies the role of a scientist as both a discoverer and a servant of the public good.

LEGACY AND FUTURE ASPIRATIONS 🚀

Looking forward, Professor Wang Qingshuang aims to expand the frontiers of biomedical diagnostics and nano-drug delivery systems. His legacy is being etched not only in academic literature but also in the generation of scientists he mentors and the technological platforms he pioneers. As he continues to collaborate with national and international institutions, his research is expected to reach broader clinical applications and influence global healthcare innovation. He envisions building interdisciplinary laboratories that integrate optics, nanotechnology, and molecular medicine, paving the way for precision diagnostics and therapies. His commitment to translational science ensures that future endeavors will continue to bridge the gap between research labs and hospital wards. With an unrelenting passion for inquiry and innovation, Professor Wang is poised to leave a lasting mark on biomedical science and public health advancement.

NOTABLE PUBLICATION

Title: Fe₂VO₄@N−C cathode for high performance aqueous zinc and ammonium-ion batteries
Authors: Yinqiang Hu, Li Lin, Zhenyu Hu, Qingshuang Wang, Chunpeng Yang
Journal: Not specified (journal name not shown in the provided text)

Title: An electrochemical biosensor based on a novel nucleic acid isothermal amplification method for detecting pathogenic bacteria
Authors: Chuanna Xu, Shengjun Bu, Boyuan Jian, Qingshuang Wang, Jiayu Wan
Journal: Microchemical Journal, 2025

Title: High capacity and efficient dehydrogenation of aluminum hydride: Optimized by highly active TiN nanoparticles with low addition
Authors: Shaolei Zhao, Qingyun Shi, Long Liang, Limin Wang, Yong Cheng
Journal: Nano Research, 2025

Title: Thermosensitive Hydrogel Loaded with α-Mangostin for Enhanced Antitumor Effect of Doxorubicin
Authors: Tianhui Liu, Qingshuang Wang, Wenxin Geng, Zhe Zhang, Xiangru Feng
Journal: ACS Biomaterials Science and Engineering, 2025

Title: Nano-Based Strategies Aiming at Tumor Microenvironment for Improved Cancer Therapy
Authors: Tianhui Liu, Changshun Lu, Xue Jiang, Xiangru Feng, Qingshuang Wang
Journal: Not specified (journal name not shown in the provided text)

Somdeb Bose Dasgupta – Microbial Pathogenesis and Virulence – Best Researcher Award

Somdeb Bose Dasgupta - Microbial Pathogenesis and Virulence - Best Researcher Award

IIT Kharagpur - India

AUTHOR PROFILE 

SCOPUS

EARLY ACADEMIC PURSUITS 🎓

Dr. Somdeb Bose Dasgupta began his scientific journey with a B.Sc in Physiology, Chemistry, and Zoology from City College, University of Calcutta, graduating with first-class honors in 2001. He pursued an M.Sc in Biophysics & Molecular Biology from Rajabazar Science College, University of Calcutta, and again secured first-class distinction. His academic rigor culminated in a Ph.D. in Molecular Parasitology from CSIR-IICB and Jadavpur University in 2009, where he was awarded the Best Thesis Award. During his doctoral years, Dr. Dasgupta delved deep into the molecular machinery of parasitic organisms, setting the foundation for a career that would be defined by his dedication to host-pathogen interactions. The exceptional clarity and originality of his doctoral research earned him early recognition in India’s scientific community, establishing a trajectory toward pioneering work in infectious diseases and immunology, especially concerning neglected tropical diseases like Leishmaniasis and Tuberculosis.

PROFESSIONAL ODYSSEY 🌍

Following his doctorate, Dr. Dasgupta expanded his scientific horizon through a postdoctoral fellowship at the University of Basel’s Biozentrum in Switzerland, from 2009 to 2014, where he worked on macrophage-pathogen interactions. This global exposure refined his research methodologies and enriched his understanding of molecular immunology. He then returned to India to contribute as an Assistant Professor at IIT (BHU) Varanasi from 2014 to 2016, before joining IIT Kharagpur in the Department of Biotechnology in 2016. At IIT Kharagpur, he rose to the position of Assistant Professor Grade I and became a pivotal figure in both undergraduate and postgraduate teaching. His courses span Molecular Biology, Neurophysiology, Biochemistry, and Bioprocess Engineering, nurturing the next generation of biotechnologists. His professional odyssey reflects a balance between international research excellence and a deep-rooted commitment to Indian scientific development. Throughout, he has maintained a clear vision: to translate basic science into therapeutic and diagnostic breakthroughs against life-threatening infectious diseases.

RESEARCH FOCUS 🔬

Dr. Dasgupta’s research lies at the intersection of molecular immunology, cellular microbiology, and genome editing. His lab investigates host-pathogen dynamics, especially in Mycobacterium tuberculosis and Leishmania donovani infections—diseases of critical importance to the Indian subcontinent. Utilizing CRISPR/Cas9 technologies, his team uncovers how host enzymes, particularly kinases and phosphatases, are manipulated by pathogens to ensure survival. His group is innovating host-directed therapeutics to bypass drug resistance by reactivating immune responses and restoring macrophage functionality. His approach includes drug repurposing strategies—like testing tricyclic antidepressants for anti-leishmanial use—and developing novel diagnostics for drug-resistant TB. Additionally, Dr. Dasgupta studies how parasitic infections influence phagosome maturation and immune modulation. His projects explore everything from biochemical pathway elucidation to advanced nanocarrier-based drug delivery systems. By combining cellular, biochemical, and genomic strategies, his lab offers crucial insights into both fundamental disease biology and translational medicine, with the aim of improving public health outcomes across endemic regions.

PIONEERING CONTRIBUTIONS 🧪

Over his career, Dr. Dasgupta has contributed over 38 research articles, five book chapters, and 25 conference proceedings, with many featured in high-impact journals like PNAS, FEBS Journal, and PLOS Pathogens. His pioneering findings—such as the discovery of how S-nitrosylation of mycobacterial Protein Kinase G (PknG) aids pathogen survival—have received global attention, including journal cover highlights and editor’s choice selections. At the forefront of translational research, he developed groundbreaking assays to study host-pathogen phospho-signaling, designed nanocarrier systems for immunomodulatory drug delivery, and repurposed common drugs into potential antiparasitic treatments. His innovations in CRISPR-based gene editing of host and pathogen genomes have redefined therapeutic targets. Further, his role in establishing India’s hybrid BSL-III facility at IIT Kharagpur has paved the way for safe, cutting-edge research on high-risk pathogens. Collectively, Dr. Dasgupta’s work bridges discovery and application, positioning him as a vanguard of molecular parasitology and infectious disease biology.

AWARDS AND RECOGNITION 🏅

Dr. Dasgupta’s scholarly excellence has been widely acknowledged. He was honored with the prestigious INSA Young Scientist Award in 2011 for contributions to biophysics and biochemistry, followed by the coveted DBT-Ramalingaswamy Fellowship in 2015. His postdoctoral research earned him the EMBO Long Term Fellowship in 2009, reflecting international acclaim. He has received multiple Best Poster Awards at national and international symposia, including the Annual Post-doc Retreats in Switzerland and the National Congress of Parasitology in India. His publications have been featured on journal covers and spotlighted for editorial distinction. He also received a DBT-CTEP Travel Award to attend the World Congress in Infectious Diseases in London, showcasing his global scientific presence. These accolades underscore both the depth and societal impact of his research. Through sustained excellence in discovery, innovation, and mentorship, Dr. Dasgupta has become a beacon in the field of molecular microbiology and immunopathology, inspiring peers and proteges alike.

IMPACT AND INFLUENCE 🌐

Dr. Dasgupta’s influence extends beyond laboratory research into public health, diagnostics, and therapeutic development. His contributions are instrumental in tackling antimicrobial resistance—one of modern medicine’s gravest challenges. By advancing host-directed therapies and creating rapid point-of-care diagnostic tools, he directly impacts clinical strategies for TB and Leishmaniasis. His leadership in major government-funded projects—ranging from ICMR, DST, DBT, to SERB—demonstrates trust in his ability to deliver translational outcomes. His work has informed national health priorities and contributed to India’s strategic push toward self-reliance in infectious disease control. As a mentor and educator, he shapes future scientists, embedding translational thinking in their academic DNA. His integrated approach, which combines molecular biology, nanotechnology, and immunology, sets a benchmark for interdisciplinary biomedical research in India. Through his visionary projects and collaborations, Dr. Dasgupta is not only solving today's biomedical problems but also laying the groundwork for long-term scientific resilience and healthcare innovation.

LEGACY AND FUTURE HORIZONS 🚀

Dr. Dasgupta’s legacy lies in transforming how we understand and combat chronic infectious diseases in resource-limited settings. His work champions a paradigm shift—from pathogen-centric drug design to host-targeted intervention, which offers sustainable solutions in the face of evolving drug resistance. The upcoming years promise even greater impact: his team is pioneering biosensors for non-invasive TB detection and leveraging liposomal drug delivery platforms for improved efficacy. With multiple ICMR-backed projects underway, including ENLIGHTEN—a non-invasive latent TB detection initiative—Dr. Dasgupta continues to chart untraveled paths in diagnostic science. He also plays a central role in shaping high-containment laboratory infrastructure to safely study dangerous pathogens. His foresight, collaborative spirit, and relentless pursuit of translational relevance ensure that his contributions will endure in both academic and clinical domains. Dr. Somdeb Bose Dasgupta is poised to remain a cornerstone of biomedical innovation, where his science continues to illuminate pathways toward global health equity.

NOTABLE PUBLICATION 

 Article Title:
Resolving the polycistronic aftermath: Essential role of topoisomerase IA in preventing R-loops in Leishmania
Authors: P. Das, A. Hazra, S. Saha, H.K. Majumdar, S. BoseDasgupta
Journal: The Journal of Biological Chemistry, 2024

 Article Title:
Gelatin-decorated Graphene oxide: A nanocarrier for delivering pH-responsive drug for improving therapeutic efficacy against atherosclerotic plaque
Authors: S.K. Yadav, S. Das, A. Lincon, S.K. Ray, S.C. Das
Journal: International Journal of Pharmaceutics, 2024